Jinfa Du

USPTO Granted Patents = 34 (Patent Applications = 7)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 18 (Patent Applications = 19)

Average Co-Inventor Count = 3.9

ph-index = 19

Forward Citations = 1,223(Granted Patents)

Location History:

Lilburn, GA (US) (2005)
New Hope, PA (US) (2009 - 2016)
Redwood City, CA (US) (2014 - 2023)

Company Filing History:

23 out of 79

Gilead Pharmasset LLC

patents

8 out of 923

Gilead Sciences, Inc.

Years Active: 2005-2024

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

2. 12121529 - Nucleoside phosphoramidate prodrugs (2024-10-22),

3. 11642361 - Nucleoside phosphoramidate prodrugs (2023-05-09),

4. 10874640 - Substituted pyrrolizine compounds and uses thereof (2020-12-29),

5. 10577359 - Preparation of 2'-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives (2020-03-03),

6. 10328053 - Substituted pyrrolizine compounds and uses thereof (2019-06-25),

7. 10183037 - Nucleoside phosphoramidate prodrugs (2019-01-22),

8. 10017501 - Benzimidazole derivatives as bromodomain inhibitors (2018-07-10),

9. 9676808 - 2',4′-substituted nucleosides as antiviral agents (2017-06-13),

10. 9585906 - Nucleoside phosphoramidate prodrugs (2017-03-07),

11. 9458145 - Benzimidazole derivatives as bromodomain inhibitors (2016-10-04),

12. 9394331 - 2'-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections (2016-07-19),

13. 9296777 - 2',4′-substituted nucleosides as antiviral agents (2016-03-29),

14. 9255089 - Benzimidazolone derivatives as bromodomain inhibitors (2016-02-09),

15. 9085573 - Nucleoside phosphoramidate prodrugs (2015-07-21),

Title: Innovations of Jinfa Du: A Pioneer in Pharmaceutical Patents

Introduction

Jinfa Du, based in New Hope, PA, is a distinguished inventor renowned for his significant contributions to pharmaceutical research. With an impressive portfolio of 34 patents, Du's innovative approach has advanced the field of medicinal chemistry, particularly in the treatment of viral infections.

Latest Patents

Among his recent inventions are the patented "Substituted Pyrrolizine Compounds and Uses Thereof," which focuses on pharmaceutical compositions that inhibit HBV replication, showcasing groundbreaking methods for the treatment of hepatitis B virus. Another notable patent, "Nucleoside Phosphoramidate Prodrugs," details innovative prodrugs of nucleoside derivatives aimed at combating viral infections in mammals. This patent includes comprehensive processes for treating these infections using the compounds referenced in the application.

Career Highlights

Jinfa Du's impressive career includes critical roles at prominent pharmaceutical companies such as Gilead Pharmasset LLC and Gilead Sciences, Inc. His work has been instrumental in developing innovative treatments that address significant health challenges, thereby enhancing the field of antiviral therapeutics.

Collaborations

Throughout his career, Du has collaborated with fellow scientists, including Michael Joseph Sofia and Peiyuan Wang. Together, they have contributed to the advancement of medicinal research, leading to numerous patents that are pivotal in the fight against viral diseases.

Conclusion

Jinfa Du's innovative spirit and extensive patent portfolio reflect a dedication to improving health outcomes through pharmaceutical advancements. His ongoing contributions symbolize the vital role of inventors in addressing global health concerns and fostering breakthroughs in medical science.

This text is generated by artificial intelligence and may not be accurate.